“Physicians and medical institutions should shun gifts, reps, samples and ghostwriting, said the Institute of Medicine‘s conflict of interest committee in its full recommendations.” More…
Who needs reps? Doctors comfortable with ePromotion. Hmmm..
Sanofi bags some experimental drugs in the pipeline. Formerly in the pipeline.
Novartis gets ongoing encouraging results for experimental MS oral drug.
Pfizer to former biotech chief: Here’s a bundle. Now shut up!
PLUS: Swine flu, Asian flu, Avian flu, Flu Flu, Flu, Flu…it’s all getting a bit much. Here’s a very brief historical perspective.
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff
Leave a Reply